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TABLE S1 
Full results of ‘Diseases and Disorders’ Ingenuity pathway and network analysis for genes with promoters enriched for CpG sites at which 
methylation levels are associated with telomere length in blood DNA (65 genes). 
Name of disease/disorder P-Value Genes No. of 
genes 
Developmental Disorders       
Beckwith-Wiedemann syndrome 9.59E-05 H19,KCNQ1OT1 2 
overgrowth syndrome 3.57E-04 H19,KCNQ1OT1,RNF135 3 
Russell-Silver syndrome 2.57E-03 H19 1 
atresia of oocytes 2.57E-03 FOXL2 1 
combined oxidative phosphorylation 
deficiency 2 
2.57E-03 MRPS16 1 
congenital amegakaryocytic 
thrombocytopenia 
2.57E-03 MPL 1 
macrocephaly, macrosomia, facial 
dysmorphism syndrome 
2.57E-03 RNF135 1 
type 1 blepharophimosis, epicanthus 
inversus, and ptosis 
2.57E-03 FOXL2 1 
type 2 blepharophimosis, epicanthus 
inversus, and ptosis 
2.57E-03 FOXL2 1 
Ehlers-Danlos syndrome type III 5.13E-03 TNXB 1 
Rubinstein-Taybi syndrome 5.13E-03 CREBBP 1 
dysplasia of placental tissue 5.13E-03 H19 1 
disorder of stature 6.09E-03 H19,HOXA5,KCNQ1OT1 3 
bare lymphocyte syndrome, type i 7.68E-03 TAPBP 1 
pseudohypoparathyroidism type 1B 7.68E-03 GNAS-AS1 1 
aphasia 1.78E-02 DRD4 1 
multiple congenital anomalies 2.63E-02 CREBBP,FOXL2,H19,KCNQ1OT1 4 
congenital anomaly of musculoskeletal 
system 
2.87E-02 CREBBP,H19,mir-10,RNF135,TNXB 5 
dysplasia 2.95E-02 H19,MRPS16,TNXB 3 
malformation of brain 3.52E-02 CREBBP,MRPS16,RNF135 3 
dwarfism 4.39E-02 H19,HOXA5 2 
Endocrine System Disorders       
Beckwith-Wiedemann syndrome 9.59E-05 H19,KCNQ1OT1 2 
diabetes mellitus 3.94E-04 CYP2E1,DRD4,mir-10,NR4A2,POU5F1,PPP1R11,TNXB,TRIM31,ZFP57 9 
insulin-dependent diabetes mellitus 1.26E-03 POU5F1,PPP1R11,TNXB,TRIM31,ZFP57 5 
pituitary dysfunction 1.34E-03 DRD4,H19,KCNQ1OT1 3 
type 1 blepharophimosis, epicanthus 
inversus, and ptosis 
2.57E-03 FOXL2 1 
transitory neonatal diabetes 5.13E-03 ZFP57 1 
pseudohypoparathyroidism type 1B 7.68E-03 GNAS-AS1 1 
thyroid cancer 1.20E-02 DIRAS3,LTB,POU5F1 3 
hyperprolactinemia 3.53E-02 DRD4 1 
chronic pancreatitis 3.78E-02 CYP2E1 1 
ovarian cancer 4.22E-02 DIRAS3,H19,HOXA5,MECOM,PRDM9 5 
metabolic syndrome X 4.39E-02 CYP2E1,DRD4 2 
Gastrointestinal Disease       
Beckwith-Wiedemann syndrome 9.59E-05 H19,KCNQ1OT1 2 
diabetes mellitus 3.94E-04 CYP2E1,DRD4,mir-10,NR4A2,POU5F1,PPP1R11,TNXB,TRIM31,ZFP57 9 
insulin-dependent diabetes mellitus 1.26E-03 POU5F1,PPP1R11,TNXB,TRIM31,ZFP57 5 
transitory neonatal diabetes 5.13E-03 ZFP57 1 
tumorigenesis of hepatocellular carcinoma 9.71E-03 LTB,MAD1L1 2 
formation of aberrant crypt foci 1.78E-02 CYP2E1 1 
meteorism 2.29E-02 HOXA5 1 
chronic hepatitis 2.47E-02 LTB,MPL 2 
formation of intestinal polyp 3.04E-02 H19 1 
incidence of hepatocellular carcinoma 3.04E-02 LTB 1 
inflammation of liver 3.24E-02 CYP2E1,LTB,MPL 3 
chronic pancreatitis 3.78E-02 CYP2E1 1 
colonic polyposis 4.77E-02 H19 1 
Hereditary Disorders       
Beckwith-Wiedemann syndrome 9.59E-05 H19,KCNQ1OT1 2 
Russell-Silver syndrome 2.57E-03 H19 1 
combined oxidative phosphorylation 
deficiency 2 
2.57E-03 MRPS16 1 
congenital amegakaryocytic 
thrombocytopenia 
2.57E-03 MPL 1 
macrocephaly, macrosomia, facial 2.57E-03 RNF135 1 
dysmorphism syndrome 
recurrent hydatidiform mole type 2 2.57E-03 KHDC3L 1 
tenascin-X-deficiency 2.57E-03 TNXB 1 
type 1 blepharophimosis, epicanthus 
inversus, and ptosis 
2.57E-03 FOXL2 1 
type 2 blepharophimosis, epicanthus 
inversus, and ptosis 
2.57E-03 FOXL2 1 
Ehlers-Danlos syndrome type III 5.13E-03 TNXB 1 
myoclonic dystonia 5.13E-03 SGCE 1 
transitory neonatal diabetes 5.13E-03 ZFP57 1 
PTEN hamartoma tumor syndrome 7.68E-03 KLLN 1 
bare lymphocyte syndrome, type i 7.68E-03 TAPBP 1 
pseudohypoparathyroidism type 1B 7.68E-03 GNAS-AS1 1 
familial Parkinson disease 3.53E-02 NR4A2 1 
dwarfism 4.39E-02 H19,HOXA5 2 
Reproductive System Disease       
Beckwith-Wiedemann syndrome 9.59E-05 H19,KCNQ1OT1 2 
genital tumor 3.60E-04 B4GALNT4,DIRAS3,FOXL2,H19,HOXA5,KHDC3L,MAD1L1,MECOM,mir-
10,mir-7,POU5F1,PRDM9 
12 
pituitary dysfunction 1.34E-03 DRD4,H19,KCNQ1OT1 3 
Sertoli-Leydig cell tumor 2.57E-03 FOXL2 1 
atresia of oocytes 2.57E-03 FOXL2 1 
fibrothecoma 2.57E-03 FOXL2 1 
recurrent hydatidiform mole type 2 2.57E-03 KHDC3L 1 
type 1 blepharophimosis, epicanthus 
inversus, and ptosis 
2.57E-03 FOXL2 1 
trophoblastic tumor 2.67E-03 KHDC3L,POU5F1 2 
dysplasia of placental tissue 5.13E-03 H19 1 
germ cell and embryonal neoplasm 1.31E-02 KHDC3L,mir-10,POU5F1 3 
ovarian tumor 1.48E-02 DIRAS3,FOXL2,H19,HOXA5,MECOM,PRDM9 6 
prostate cancer 1.62E-02 B4GALNT4,DIRAS3,MAD1L1,mir-10,mir-7,PRDM9 6 
granulosa cell tumor 2.79E-02 FOXL2 1 
hyperprolactinemia 3.53E-02 DRD4 1 
ovarian cancer 4.22E-02 DIRAS3,H19,HOXA5,MECOM,PRDM9 5 
 
